Invitrall

Over 90% of drugs fail in clinical trials, largely due to the limited representativeness of preclinical models. Traditional models, whether animal or in vitro, fail to effectively capture the complexity and genetic diversity of humans. At Invitrall, we are overcoming this challenge. We develop adva... Read more